• 1
    Buchanan JW. Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci Comp Med J Vet Cardiol 2004;6:67.
  • 2
    Borgarelli M, Zini E, D'Agnolo G, et al. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. J Vet Cardiol 2004;6:2734.
  • 3
    Beardow AW, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987–1991). J Am Vet Med Assoc 1993;203:10231029.
  • 4
    Häggström J, Hansson K, Kvart C, Swenson L. Chronic valvular disease in the Cavalier King Charles Spaniel in Sweden. Vet Rec 1992;131:549553.
  • 5
    Swenson L, Haggstrom J, Kvart C, Juneja RK. Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspring. J Am Vet Med Assoc 1996;208:20092012.
  • 6
    Olsen LH, Fredholm M, Pedersen HD. Epidemiology and inheritance of mitral valve prolapse in Dachshunds. J Vet Intern Med 1999;13:448456.
  • 7
    Black A, French AT, Dukes-McEwan J, Corcoran BM. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. Am J Vet Res 2005;66:14081414.
  • 8
    Han RI, Black A, Culshaw GJ, et al. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. Am J Vet Res 2008;69:763769.
  • 9
    Hadian M, Corcoran BM, Han RI, et al. Collagen organization in canine myxomatous mitral valve disease: An X-ray diffraction study. Biophys J 2007;93:24722476.
  • 10
    Hadian M, Corcoran B, Bradshaw J. A differential scanning calorimetry study of collagen phase transition in myxomatous mitral valves. Biophys J 2007;44A.
  • 11
    Corcoran BM, Black A, Anderson H, et al. Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration. Am J Vet Res 2004;65:198206.
  • 12
    Pedersen HD, Lorentzen KA, Kristensen BO Echocardiographic mitral valve prolapse in Cavalier King Charles Spaniels: Epidemiology and prognostic significance for regurgitation. Vet Rec 1999;144:315320.
  • 13
    Mow T, Pedersen HD. Increased endothelin-receptor density in myxomatous canine mitral valve leaflets. J Cardiovasc Pharmacol 1999;34:254260.
  • 14
    Olsen LH, Mortensen K, Martinussen T, et al. Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets. J Comp Pathol 2003;129:120130.
  • 15
    Borgarelli M, Savarino P, Crosara S, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120128.
  • 16
    Atkins CE, Keene BW, Brown WA, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 2007;231:10611069.
  • 17
    Ettinger SJ, Suter PF The recognition of cardiac disease and congestive heart failure. In: EttingerSF, DuterPF. Canine Cardiology. Philadelphia, PA: WB Saunders; 1970: p. 5.
  • 18
    International Small Animal Cardiac Health Council. Recommendations for the diagnosis and treatment of heart failure in small animals. Woodbridge, NJ: ISACHC Publication; 1994: p. 5.
  • 19
    Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2001;38:21012113.
  • 20
    Kvart C, Haggstrom J, Pedersen HD, et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 2002;16:8088.
  • 21
    Atkins CE, Brown WA, Coats JR, et al. Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation. J Am Vet Med Assoc 2002;221:654658.
  • 22
    Pouchelon JL, Jamet N, Gouni V, et al. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: A retrospective study of 141 cases. J Vet Intern Med 2008;22:905914.
  • 23
    Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med 2003;17:632636.
  • 24
    Ichihara K, Abiko Y. The effect of pimobendan on myocardial mechanical function and metabolism in dogs: Comparison with dobutamine. J Pharm Pharmacol 1991;43:583588.
  • 25
    Pouleur H, Gurne O, Hanet C, et al. Effects of pimobendan (UD-CG 115) on the contractile function of the normal and “postischemic” canine myocardium. J Cardiovasc Pharmacol 1988;11:100106.
  • 26
    Pouleur H, Hanet C, Schroder E, et al. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure. J Cardiovasc Pharmacol 1989;14 (Suppl 2):S18S22.
  • 27
    Takahashi R, Endoh M. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium. J Cardiovasc Pharmacol 2001;37:209218.
  • 28
    Haggstrom J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study. J Vet Intern Med 2008;22:11241135.
  • 29
    Smith PJ, French AT, Van IN, et al. Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. J Small Anim Pract 2005;46:121130.
  • 30
    Lombard CW, Jöns O, Bussadori CM. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 2006;42:249261.
  • 31
    Tsutsui H, Spinale FG, Nagatsu M, et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994;93:26392648.
  • 32
    Slupe JL, Freeman LM, Rush JE. Association of body weight and body condition with survival in dogs with heart failure. J Vet Intern Med 2008;22:561565.
  • 33
    Thomason JD, Rockwell JE, Fallaw TK, Calvert CA. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease. J Vet Cardiol 2007;9:103108.
  • 34
    Slupe JL, Freeman LM, Rush JE. Association of body weight and body condition with survival in dogs with heart failure. J Vet Intern Med 2008;22:561565.
  • 35
    Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med 2003;17:632636.